Back to Search
Start Over
Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease
- Source :
- Case Reports in Ophthalmological Medicine.
- Publication Year :
- 2021
- Publisher :
- Hindawi, 2021.
-
Abstract
- We report the rescue effect of intravitreal aflibercept injections on retinal neovascularization and macular edema due to Eales disease. Case 1 was a 36-year-old female. Intravitreal aflibercept was administered as rescue therapy after persistent retinal neovascularization following retinal photocoagulation, periocular triamcinolone, and intravitreal ranibizumab injection. Retinal neovascularization initially regressed, but recurred after 5 months along with macular edema. Two more intravitreal aflibercept injections were given, and retinal neovascularization with macular edema regressed. Her vision improved to 20/25 and remained stable after 43 months. Case 2 was a 27-year-old female. Intravitreal aflibercept was administered after persistent retinal neovascularization and macular edema following periocular triamcinolone injection. The macular edema initially subsided but recurred after 3 months. Intravitreal aflibercept injections were then administered once every three months to maintain her vision 20/20. The patient has been followed up for 28 months. Intravitreal aflibercept was effective as a rescue therapy in the treatment of Eales disease to regress retinal neovascularization, though repeated injections were necessary in cases of recurrence.
- Subjects :
- genetic structures
Article Subject
sense organs
eye diseases
Subjects
Details
- Language :
- English
- ISSN :
- 20906722
- Database :
- OpenAIRE
- Journal :
- Case Reports in Ophthalmological Medicine
- Accession number :
- edsair.hindawi.publ..5a0f811098ccd591f4407089b6367e6a
- Full Text :
- https://doi.org/10.1155/2021/8887362